Clinical Trial Update: ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of ECT-001 (UM171) expanded cord blood transplant for high-risk multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ECT-001 (UM171) (UM171)

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED